Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Oct 18, 2024
Total Value: $1.31B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | 8,707,165 | $187M | 14.2% | $19.43 | -0.1% | COM NEW | 09062W204 |
| RVMD | REVOLUTION MEDICINES INC | 4,406,875 | $171M | 13.1% | $25.89 | +44.3% | COM | 76155X100 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,073,500 | $170M | 13.0% | $100.84 | +27.4% | COM | 803607100 |
| LAB | STANDARD BIOTOOLS INC | 63,959,677 | $113M | 8.6% | $2.41 | +1.6% | COM | 34385P108 |
| WGS | GENEDX HOLDINGS CORP | 3,526,411 | $92.18M | 7.0% | $9.11 | +108.0% | COM CL A | 81663L200 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,084,841 | $85.17M | 6.5% | $14.11 | +103.4% | COM | 05370A108 |
| RLAY | RELAY THERAPEUTICS INC | 8,448,574 | $55.08M | 4.2% | $21.12 | -67.7% | COM | 75943R102 |
| ILMN | ILLUMINA INC | 480,000 | $50.1M | 3.8% | $117.23 | -4.3% | COM | 452327109 |
| NTLA | INTELLIA THERAPEUTICS INC | 2,000,000 | $44.76M | 3.4% | $37.51 | -36.5% | COM | 45826J105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 170,000 | $41.31M | 3.2% | $138.08 | +14.3% | COM | 02043Q107 |
| — | BLUEPRINT MEDICINES CORP | 326,378 | $35.18M | 2.7% | $3820.05 | — | COM | 09627Y109 |
| DNLI | DENALI THERAPEUTICS INC | 1,300,000 | $30.19M | 2.3% | $29.48 | -34.9% | COM | 24823R105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 700,000 | $27.49M | 2.1% | $33.80 | — | SPONSORED ADS | 86366E106 |
| EXAS | EXACT SCIENCES CORP | 650,000 | $27.46M | 2.1% | $74.77 | -26.4% | COM | 30063P105 |
| TNYA | TENAYA THERAPEUTICS INC | 6,732,971 | $20.87M | 1.6% | $12.86 | -67.9% | COM | 87990A106 |
| NGNE | NEUROGENE INC | 524,616 | $19.09M | 1.5% | $14.32 | +146.3% | COM | 64135M105 |
| VCYT | VERACYTE INC | 857,904 | $18.59M | 1.4% | $24.40 | -13.8% | COM | 92337F107 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 800,000 | $16.79M | 1.3% | $17.09 | +46.8% | COM | 35104E100 |
| BEAM | BEAM THERAPEUTICS INC | 675,000 | $15.82M | 1.2% | $52.81 | -53.5% | COM | 07373V105 |
| — | VERVE THERAPEUTICS INC | 3,059,094 | $14.93M | 1.1% | $45.54 | — | COM | 92539P101 |
| IPSC | CENTURY THERAPEUTICS INC | 5,190,506 | $13.24M | 1.0% | $16.88 | -81.3% | COM | 15673T100 |
| PLRX | PLIANT THERAPEUTICS INC | 1,000,000 | $10.75M | 0.8% | $20.16 | -36.1% | COM | 729139105 |
| TNGX | TANGO THERAPEUTICS INC | 1,188,349 | $10.2M | 0.8% | $5.87 | +31.6% | COM | 87583X109 |
| — | 2SEVENTY BIO INC | 2,000,000 | $7.7M | 0.6% | $9.15 | — | COMMON STOCK | 901384107 |
| CDXS | CODEXIS INC | 2,000,000 | $6.2M | 0.5% | $2.18 | +47.5% | COM | 192005106 |
| CTNM | CONTINEUM THERAPEUTICS INC | 296,666 | $5.224M | 0.4% | $16.10 | 0.0% | CL A | 21217B100 |
| KYTX | KYVERNA THERAPEUTICS INC | 575,000 | $4.313M | 0.3% | $18.55 | -17.7% | COM | 501976104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 150,000 | $3.079M | 0.2% | $15.37 | +36.1% | COM | 87164F105 |
| ABSI | ABSCI CORPORATION | 973,260 | $2.998M | 0.2% | $19.41 | -76.1% | COM | 00091E109 |
| GH | GUARDANT HEALTH INC | 100,000 | $2.888M | 0.2% | $23.27 | 0.0% | COM | 40131M109 |
| PRME | PRIME MEDICINE INC | 367,175 | $1.887M | 0.1% | $18.06 | -66.4% | COM | 74168J101 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $1.419M | 0.1% | $11.43 | -82.3% | COM | 69404D108 |
| GRAL | GRAIL INC | 79,999 | $1.23M | 0.1% | $16.22 | 0.0% | COM | 384747101 |
| — | EXSCIENTIA PLC | 213,900 | $1.091M | 0.1% | $19.76 | — | ADS | 30223G102 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 261,014 | $976K | 0.1% | $20.37 | -75.0% | COM | 61225M102 |
| — | GINKGO BIOWORKS HOLDINGS INC | 1,459,747 | $488K | 0.0% | $1.16 | — | CL A SHS | 37611X100 |
| — | SINGULAR GENOMICS SYSTEMS IN | 44,129 | $373K | 0.0% | $8.45 | — | COM NEW | 82933R308 |
| — | KRONOS BIO INC | 123,839 | $154K | 0.0% | $29.87 | — | COM | 50107A104 |